slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 38,131-38,160
Pages 1,935
Rows per page 30
Slide function
38,131-38,160 of 58,039
23
Includes a footnote regarding the exclusion of $8.4 million Orten acquisition cancellation in 3Q 2022.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
24
Includes footnotes regarding legal contingencies and SEC settlements.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
08
The slide uses a funnel-like progression for the pipeline and highlights specific customer logos under the 'Contracted Fleets' stage.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Rising Success1 hit
15
The table includes both GAAP financial metrics and supplemental non-GAAP/operational data.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
16
The data shows a significant spike in legal/consulting/accounting fees in Q2 2023 due to SEC investigation accruals.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
17
The table includes footnotes explaining specific adjustments to the figures.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
19
The table includes adjustments for fair value changes, stock-based compensation, and legal/regulatory matters.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
20
The table displays clinical trial data for NXC-201, including toxicity management metrics like Tocilizumab and Dexamethasone usage.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
23
The table uses a red dashed box to highlight the core clinical data rows.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
25
The table highlights clinical safety data for NXC-201, showing low incidence of severe adverse events.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
14
The slide explains the revenue decline YoY as a strategic shift in business model (selling components vs full units).Innoviz | Results Presentation Deck | 18 slides · Innoviz
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
04
The slide highlights a CAGR of 5.3% for book value and an average ROE of 13.4% over the period, with a specific callout for the 2020 Nasdaq listing.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · WhyLoop · Benchmark Gap1 hit
09
The slide uses a side-by-side comparison structure for two distinct time periods.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction1 hit
10
The slide highlights diversification across multiple dimensions including geography and lines of business.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction1 hit
11
The chart uses a stacked bar for GWP (Reinsurance, Long-Tail, Short-Tail) and a line chart for the Combined Ratio.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction1 hit
12
The chart uses a dual-axis approach: stacked bars for loss amounts ($Billions) and a line graph for the Combined Ratio (%).International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction1 hit
13
The slide highlights a conservative strategy with a high concentration in A-rated bonds and a 3.1-year duration.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction1 hit
14
The slide highlights the company's approach to IBNR reserves and balance sheet management.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction1 hit
17
The table distinguishes between IFRS (audited) and U.S. GAAP (unaudited) reporting standards.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations 1 hit
18
The table includes annual data from 2017-2022 under IFRS and U.S. GAAP, plus quarterly comparisons for 2022 and 2023.International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations 1 hit
19
The slide presents two distinct tables: one for IFRS (2017-2020) and one for U.S. GAAP (2021-2023).International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations 1 hit
10
Includes a footnote regarding pro-forma adjustments and rounding.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Zoom In1 hit
11
The slide uses stacked bar charts to show revenue composition across four segments: Data/Patient Network, Women's health, Rare diseases/Other, and Oncology.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Zoom In1 hit
12
The table includes specific line items for revenue, margins, operating expenses, and cash position.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Zoom In1 hit
13
The chart shows a consistent upward trend in gross margin over the 8 quarters presented.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
14
The slide includes detailed footnotes explaining adjustments to the cash burn figures for specific quarters.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
15
Includes footnotes regarding non-GAAP measures and revenue/patient calculation exclusions.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
16
Includes footnotes regarding pro forma revenue and cash burn definitions.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
21
Includes pro forma adjustments for exited businesses and geographies.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations 1 hit
22
Pro forma figures exclude exited businesses and geographies.Invitae | Results Presentation Deck | 28 slides · Invitae
Conference presentation Investor relations 1 hit